Aureus Asset Management, LLC

Position in NVO — Novo Nordisk A S

CIK 1381296 BOSTON, MA

Position in NVO

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,304,926

+$304,591 QoQ

Shares Held

27,220

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#460

of 1,348 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aureus Asset Management, LLC holds $14,021,737 across 9 Drug Manufacturers - General names. NVO ranks #6 (9.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	3,359	$4,028,885
2	JNJ	Johnson & Johnson	9,201	$2,336,777
3	AMGN	Amgen Inc	4,987	$1,805,892
4	ABBV	AbbVie Inc.	6,899	$1,736,064
5	MRK	Merck & Co., Inc.	11,833	$1,520,540
6	NVO	Novo Nordisk A S This page	27,220	$1,304,926
7	NVS	Novartis AG	5,586	$875,437
8	AZN	Astrazeneca PLC	1,105	$209,530

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,304,926	27,220	0.0%	Shares	Sole	2026-08-14
2026-03-31	$1,000,335	27,220	-7.1%	Shares	Sole	2026-05-13
2025-12-31	$1,490,987	29,304	-1.5%	Shares	Sole	2026-02-17
2025-09-30	$1,650,106	29,737	+406.1%	Shares	Sole	2025-11-17
2025-06-30	$405,561	5,876	+145.4%	Shares	Sole	2025-08-14
2024-12-31	$205,931	2,394	0.0%	Shares	Sole	2025-02-14
2024-09-30	$285,053	2,394	-3.3%	Shares	Sole	2024-11-14
2024-06-30	$353,281	2,475	0.0%	Shares	Sole	2024-08-13
2024-03-31	$317,790	2,475	0.0%	Shares	Sole	2024-05-13
2023-12-31	$256,038	2,475	0.0%	Shares	Sole	2024-02-14
2023-09-30	$225,076	2,475	+86.7%	Shares	Sole	2023-11-13
2023-06-30	$214,586	1,326	0.0%	Shares	Sole	2023-08-11
2023-03-31	$211,019	1,326	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.